| Tretinoin | Approved Investigational Nutraceutical | GABRP | 2568 |
upregulated | Tretinoin results in increased expression of GABRP mRNA | 5q35.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GABRR1 | 2569 |
upregulated | Tretinoin results in increased expression of GABRR1 mRNA | 6q15 | |
| Tretinoin | Approved Investigational Nutraceutical | GAD1 | 2571 |
downregulated | Tretinoin results in decreased expression of GAD1 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GADD45A | 1647 |
downregulated | Tretinoin results in decreased expression of GADD45A mRNA | 1p31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GADD45A | 1647 |
upregulated | Tretinoin results in increased expression of GADD45A mRNA | 1p31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GADD45G | 10912 |
downregulated | Tretinoin results in decreased expression of GADD45G mRNA | 9q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GAL | 51083 |
downregulated | Tretinoin results in decreased expression of GAL mRNA | 11q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GALK2 | 2585 |
downregulated | Tretinoin results in decreased expression of GALK2 mRNA | 15q21.1-q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GALM | 130589 |
upregulated | Tretinoin results in increased expression of GALM mRNA | 2p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GALNT12 | 79695 |
downregulated | Tretinoin results in decreased expression of GALNT12 mRNA | 9q22.33 | |
| Tretinoin | Approved Investigational Nutraceutical | GALNT12 | 79695 |
upregulated | Tretinoin results in increased expression of GALNT12 mRNA | 9q22.33 | |
| Tretinoin | Approved Investigational Nutraceutical | GALNT14 | 79623 |
upregulated | Tretinoin results in increased expression of GALNT14 mRNA | 2p23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GALNT3 | 2591 |
upregulated | Tretinoin results in increased expression of GALNT3 mRNA | 2q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GALNT6 | 11226 |
upregulated | Tretinoin results in increased expression of GALNT6 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | GALT | 2592 |
upregulated | Tretinoin results in increased expression of GALT mRNA | 9p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GAP43 | 2596 |
upregulated | Tretinoin results in increased expression of GAP43 mRNA | 3q13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | GAREM1 | 64762 |
downregulated | Tretinoin results in decreased expression of GAREM1 mRNA | 18q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GARS | 2617 |
downregulated | Tretinoin results in decreased expression of GARS mRNA | 7p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GART | 2618 |
downregulated | Tretinoin results in decreased expression of GART mRNA | 21q22.11 | |
| Tretinoin | Approved Investigational Nutraceutical | GAS1 | 2619 |
downregulated | Tretinoin results in decreased expression of GAS1 mRNA | 9q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | GAS2 | 2620 |
upregulated | Tretinoin results in increased expression of GAS2 mRNA | 11p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GAS7 | 8522 |
upregulated | Tretinoin results in increased expression of GAS7 mRNA | 17p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GATA2 | 2624 |
downregulated | Tretinoin results in decreased expression of GATA2 mRNA | 3q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GATA2 | 2624 |
upregulated | Tretinoin results in increased expression of GATA2 mRNA | 3q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GATA3 | 2625 |
upregulated | Tretinoin results in increased expression of GATA3 mRNA | 10p14 | |